Status:
UNKNOWN
The Effects of Melatonin on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients
Lead Sponsor:
National Nutrition and Food Technology Institute
Conditions:
Peritoneal Dialysis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The aim of this double-blind randomized clinical trial is to determine the effects of Melatonin on cardiovascular disease risk factors, bone metabolism markers, serum concentrations of advanced glycat...
Eligibility Criteria
Inclusion
- Continuous Ambulatory Peritoneal Dialysis for 6 months or more
- Body mass index (BMI) below 35
Exclusion
- Infectious diseases (especially peritonitis) and inflammatory diseases Liver diseases
- Past medical history of cancer Receiving glucocorticoid drugs, non-steroidal anti-inflammatory drugs
- Receiving Melatonin supplements
Key Trial Info
Start Date :
October 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT06096558
Start Date
October 20 2023
End Date
May 1 2024
Last Update
October 23 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.